- Previous Close
4.1900 - Open
4.1700 - Bid 4.1200 x 400
- Ask 4.1500 x 800
- Day's Range
4.0800 - 4.2100 - 52 Week Range
1.6900 - 4.2400 - Volume
1,081,868 - Avg. Volume
949,542 - Market Cap (intraday)
993.575M - Beta (5Y Monthly) 2.21
- PE Ratio (TTM)
-- - EPS (TTM)
-1.4800 - Earnings Date Oct 30, 2024 - Nov 4, 2024
- Forward Dividend & Yield 0.04 (0.97%)
- Ex-Dividend Date Jul 22, 2024
- 1y Target Est
4.00
DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of December 31, 2023, DHC's approximately $7.2 billion portfolio included 371 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.6 million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of December 31, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA.
www.dhcreit.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: DHC
View More
Performance Overview: DHC
Trailing total returns as of 10/1/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DHC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DHC
View MoreValuation Measures
Market Cap
993.57M
Enterprise Value
3.65B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.68
Price/Book (mrq)
0.46
Enterprise Value/Revenue
2.50
Enterprise Value/EBITDA
19.86
Financial Highlights
Profitability and Income Statement
Profit Margin
-24.14%
Return on Assets (ttm)
-0.87%
Return on Equity (ttm)
-15.13%
Revenue (ttm)
1.46B
Net Income Avi to Common (ttm)
-352.46M
Diluted EPS (ttm)
-1.4800
Balance Sheet and Cash Flow
Total Cash (mrq)
265.56M
Total Debt/Equity (mrq)
136.88%
Levered Free Cash Flow (ttm)
143.54M
Research Analysis: DHC
View MoreCompany Insights: DHC
DHC does not have Company Insights
Research Reports: DHC
View MoreLowering target price to $0.64
DIVERSIFIED HEALTHCARE TRUST has an Investment Rating of SELL; a target price of $0.640000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetLowering target price to $0.79
DIVERSIFIED HEALTHCARE TRUST has an Investment Rating of SELL; a target price of $0.792000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetLowering target price to $0.83
DIVERSIFIED HEALTHCARE TRUST has an Investment Rating of SELL; a target price of $0.832000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetLowering target price to $0.91
DIVERSIFIED HEALTHCARE TRUST has an Investment Rating of SELL; a target price of $0.912000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Low; and a Value Subrating of Low.
RatingPrice Target